Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma. Chaiyawat P, Klangjorhor J, Settakorn J, Champattanachai V, Phanphaisarn A, Teeyakasem P, Svasti J, Pruksakorn D*. Transl Oncol 2017;10(5):846-53.

01 Oct 2017
0

Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma.

Chaiyawat P, Klangjorhor J, Settakorn J, Champattanachai V, Phanphaisarn A, Teeyakasem P, Svasti J, Pruksakorn D*.

Transl Oncol 2017;10(5):846-53.

Tags

Share this

Related Posts

The combination of arginine deprivation and 5-fluorouracil improves therapeutic efficacy in argininosuccinatesynthetase negative hepatocellular carcinoma. Thongkum, A., Wu, C., Li, Y. Y., Wangpaichitr, M., Navasumrit, P., Parnlob, V., Savaraj, N. (2017). International Journal of Molecular Sciences, 18(6).

Recent Posts